Data / Form D filings / AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC.
AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC.: Form D filings
AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC., a biotechnology company in Rockville, MD, filed 5 Form D notices with the SEC between 2013 and 2025. The latest, on December 22, 2025, reports $310,000 sold of a $10 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 108 MONROE STREET, SUITE 202, Rockville, MD, 20850
- Phone
- (301) 337-2100
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1586824
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 22, 2025 | Amendment | $10,000,000 | $310,000 | $9,690,000 | 4 | Nov 3, 2025 | sec.gov |
| Nov 18, 2025 | New notice | $10,000,000 | $0 | $10,000,000 | 0 | Yet to occur | sec.gov |
| Nov 12, 2015 | New notice | $4,350,000 | $1,163,007 | $3,186,993 | 14 | Oct 30, 2015 | sec.gov |
| Oct 3, 2014 | New notice | $1,999,999 | $340,992 | $1,659,007 | 1 | Sep 24, 2014 | sec.gov |
| Sep 16, 2013 | New notice | $1,324,999 | $1,324,999 | 2 | Sep 3, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| William Drew Palin | Executive Officer, Director | |
| Jeffrey Adam Galvin | Executive Officer, Director | |
| Barry Haden Wells | Director |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
Every Form D from the week of Dec 22, 2025 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.